NCT00435591

A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia

A Phase 4, Randomized, Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 121 (actual)
• Sponsor: Cumberland Pharmaceuticals · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The study will evaluate the effectiveness and safety of multiple dosing regimens of IV conivaptan in subjects with euvolemic or hypervolemic hyponatremia

Conditions

• Hyponatremia
• Euvolemia
• Hypervolemia

Interventions

Type	Name	Description
DRUG	Conivaptan	ampoule or premix bag
DRUG	placebo	ampoule or premix bag

Timeline

• Start date: 2007-01-01
• Primary completion: 2008-09-01
• Completion: 2008-09-01
• First posted: 2007-02-15
• Last updated: 2014-05-15
• Results posted: 2010-05-26

Locations

18 sites across 3 countries: United States, India, Israel